David Reith

2.8k total citations
124 papers, 2.0k citations indexed

About

David Reith is a scholar working on Pediatrics, Perinatology and Child Health, Emergency Medicine and Economics and Econometrics. According to data from OpenAlex, David Reith has authored 124 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pediatrics, Perinatology and Child Health, 22 papers in Emergency Medicine and 19 papers in Economics and Econometrics. Recurrent topics in David Reith's work include Poisoning and overdose treatments (21 papers), Pharmaceutical studies and practices (19 papers) and Pharmaceutical Economics and Policy (15 papers). David Reith is often cited by papers focused on Poisoning and overdose treatments (21 papers), Pharmaceutical studies and practices (19 papers) and Pharmaceutical Economics and Policy (15 papers). David Reith collaborates with scholars based in New Zealand, Australia and United States. David Reith's co-authors include Ian M. Whyte, Roland Broadbent, Natalie J. Medlicott, June Tordoff, Gregory Carter, Michelle McPherson, Benjamin J. Wheeler, Nicholas A. Buckley, Pauline Norris and John Fountain and has published in prestigious journals such as SHILAP Revista de lepidopterología, The British Journal of Psychiatry and Health Psychology.

In The Last Decade

David Reith

121 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Reith New Zealand 25 549 362 329 255 253 124 2.0k
Russell R. Miller United States 27 258 0.5× 345 1.0× 208 0.6× 169 0.7× 144 0.6× 68 3.5k
Martin Schulz Germany 31 538 1.0× 345 1.0× 120 0.4× 315 1.2× 325 1.3× 155 4.1k
Daniel J. Cobaugh United States 25 238 0.4× 1.1k 3.1× 171 0.5× 239 0.9× 261 1.0× 54 2.2k
Salmaan Kanji Canada 31 235 0.4× 209 0.6× 191 0.6× 362 1.4× 77 0.3× 128 3.3k
Marco L.A. Sivilotti Canada 36 321 0.6× 1.0k 2.8× 296 0.9× 168 0.7× 536 2.1× 135 3.8k
Anna K. Jönsson Sweden 26 317 0.6× 159 0.4× 93 0.3× 202 0.8× 140 0.6× 65 1.8k
Brian L. Erstad United States 37 487 0.9× 610 1.7× 199 0.6× 269 1.1× 159 0.6× 279 5.1k
Michael W. Shannon United States 21 319 0.6× 718 2.0× 79 0.2× 225 0.9× 135 0.5× 42 1.8k
Matitiahu Berkovitch Israel 30 928 1.7× 143 0.4× 117 0.4× 389 1.5× 202 0.8× 184 3.3k
Maryann Mazer‐Amirshahi United States 24 306 0.6× 371 1.0× 99 0.3× 170 0.7× 70 0.3× 133 1.8k

Countries citing papers authored by David Reith

Since Specialization
Citations

This map shows the geographic impact of David Reith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Reith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Reith more than expected).

Fields of papers citing papers by David Reith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Reith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Reith. The network helps show where David Reith may publish in the future.

Co-authorship network of co-authors of David Reith

This figure shows the co-authorship network connecting the top 25 collaborators of David Reith. A scholar is included among the top collaborators of David Reith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Reith. David Reith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chin, Paul K. L., Kellie A. Charles, Bridin Murnion, et al.. (2023). Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand. British Journal of Clinical Pharmacology. 89(10). 3105–3115. 4 indexed citations
2.
Leitch, Sharon, Susan Dovey, Katharine Wallis, et al.. (2021). Epidemiology of healthcare harm in New Zealand general practice: a retrospective records review study. BMJ Open. 11(7). e048316–e048316. 2 indexed citations
3.
Reith, David, et al.. (2019). Developmental outcomes at age four following maternal antiepileptic drug use. Epilepsy & Behavior. 93. 73–79. 12 indexed citations
4.
Müller, Marion, Benjamin J. Wheeler, Mathilde Colas, et al.. (2018). The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus. Journal of Diabetes & Metabolic Disorders. 17(2). 159–163. 4 indexed citations
5.
Reith, David, et al.. (2018). Deprivation and inequalities lead to worse outcomes with dabigatran etexilate. Journal of Primary Health Care. 10(4). 303–311. 2 indexed citations
6.
Healey, Dione, Andrew Gray, Barry Taylor, et al.. (2018). The role of parent and child self-regulation in children’s glycemic control.. Health Psychology. 37(4). 326–333. 10 indexed citations
7.
Jayathissa, Sisira, et al.. (2017). Refining metformin prescribing in New Zealand.. PubMed. 130(1452). 49–53. 1 indexed citations
8.
Dovey, Susan, Sharon Leitch, Katharine Wallis, et al.. (2017). Epidemiology of Patient Harms in New Zealand: Protocol of a General Practice Records Review Study. JMIR Research Protocols. 6(1). e10–e10. 7 indexed citations
9.
Tomlin, Andrew, David Reith, David Woods, et al.. (2017). A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients. Drug Safety. 40(12). 1259–1277. 10 indexed citations
10.
Tordoff, June, et al.. (2016). Using an Electronic Decision Support Tool to Reduce Inappropriate Polypharmacy and Optimize Medicines: Rationale and Methods. JMIR Research Protocols. 5(2). e105–e105. 10 indexed citations
11.
Wheeler, Benjamin J., et al.. (2014). Insulin Pump–Associated Adverse Events in Children and Adolescents—A Prospective Study. Diabetes Technology & Therapeutics. 16(9). 558–562. 51 indexed citations
13.
Horsburgh, Simon, Mira Harrison‐Woolrych, June Tordoff, et al.. (2009). Prescribing and dispensing data sources in New Zealand: their usage and future directions. CLOK (University of Central Lancashire). 6 indexed citations
14.
Sherwin, Catherine M.T., et al.. (2009). Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis. European Journal of Clinical Pharmacology. 65(7). 705–713. 47 indexed citations
15.
Reith, David & Liza Edmonds. (2007). Assessing the Role of Drugs in Suicidal Ideation and Suicidality. CNS Drugs. 21(6). 463–472. 29 indexed citations
16.
Tordoff, June, Pauline Norris, Julia Kennedy, & David Reith. (2006). The influence of PHARMAC's National Hospital Pharmaceutical Strategy on Quality Use of Medicines activities in New Zealand hospitals.. PubMed. 119(1239). U2100–U2100. 1 indexed citations
17.
Grant, Kenneth A., et al.. (2006). Continuation of Proton Pump Inhibitors from Hospital to Community. Pharmacy World & Science. 28(4). 189–193. 63 indexed citations
18.
Tordoff, June, Pauline Norris, Julia Kennedy, & David Reith. (2005). Quality Use of Medicines activities in New Zealand hospitals from 2000 to 2002.. PubMed. 118(1208). U1259–U1259. 9 indexed citations
19.
Fountain, John, David Reith, & Martin Watts. (2005). Comparison of CD-Rom and Internet access to clinical information. International Journal of Medical Informatics. 74(9). 769–777. 7 indexed citations
20.
Reith, David, et al.. (2003). Information sources accessed by parents following childhood poisoning. Emergency Medicine. 15(4). 348–352. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026